{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T00:39:46Z","timestamp":1793147986456,"version":"4.5.0"},"reference-count":36,"publisher":"European Respiratory Society (ERS)","issue":"2","license":[{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003793","name":"Hj\u00e4rt-Lungfonden","doi-asserted-by":"publisher","award":["2019-0478"],"award-info":[{"award-number":["2019-0478"]}],"id":[{"id":"10.13039\/501100003793","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003793","name":"Hj\u00e4rt-Lungfonden","doi-asserted-by":"publisher","award":["2020-0452"],"award-info":[{"award-number":["2020-0452"]}],"id":[{"id":"10.13039\/501100003793","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["publications.ersnet.org"],"crossmark-restriction":true},"short-container-title":["ERJ Open Res"],"accepted":{"date-parts":[[2021,3,7]]},"published-print":{"date-parts":[[2021,4]]},"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>The rate of type 2 diabetes mellitus (T2D) is increased in sarcoidosis patients but it is unknown if corticosteroid treatment plays a role. We investigated whether the T2D risk is higher in untreated and corticosteroid-treated sarcoidosis patients compared with the general population.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>In this cohort study, individuals with two or more International Statistical Classification of Diseases and Related Health Problems (ICD) codes for sarcoidosis were identified from the Swedish National Patient Register (NPR) (n=5754). Corticosteroid dispensations within 3\u2005months before or after the first sarcoidosis diagnosis were identified from the Swedish Prescribed Drug Register (PDR). General population comparators without sarcoidosis were matched to cases 10:1 on age, sex and region of residence (n=61\u200a297). Incident T2D was identified using ICD codes (NPR) and antidiabetic drug dispensations (PDR). Follow-up was from the second sarcoidosis diagnosis\/matching date until T2D, emigration, death or study end (December 2013). Cox regression models adjusted for age, sex, education, country of birth, healthcare regions and family history of diabetes were used to estimate hazard ratios (HRs). We used flexible parametric models to examine the T2D risk over time.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>40% of sarcoidosis patients were treated with corticosteroid at diagnosis. The T2D rate was 7.7 per 1000\u2005person-years in untreated sarcoidosis, 12.7 per 1000\u2005person-years in corticosteroid-treated sarcoidosis and 5.5 per 1000\u2005person-years in comparators. The HR for T2D was 1.4 (95% CI 1.2\u20131.8) associated with untreated sarcoidosis and 2.3 (95% CI 2.0\u20133.0) associated with corticosteroid-treated sarcoidosis. The T2D risk was highest for corticosteroid-treated sarcoidosis in the first 2\u2005years after diagnosis.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>Sarcoidosis is associated with an increased risk of T2D especially in older, male, corticosteroid-treated patients at diagnosis. Screening for T2D for these patients is advisable.<\/jats:p><\/jats:sec>","DOI":"10.1183\/23120541.00028-2021","type":"journal-article","created":{"date-parts":[[2021,4,15]],"date-time":"2021-04-15T16:11:15Z","timestamp":1618503075000},"page":"00028-2021","update-policy":"https:\/\/doi.org\/10.1183\/ers-crossmark-policy","source":"Crossref","is-referenced-by-count":33,"title":["Type 2 diabetes risk in sarcoidosis patients untreated and treated with corticosteroids"],"prefix":"10.1183","volume":"7","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1614-8096","authenticated-orcid":false,"given":"Joshua P.","family":"Entrop","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2844-4773","authenticated-orcid":false,"given":"Susanna","family":"Kullberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johan","family":"Grunewald","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anders","family":"Eklund","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kerstin","family":"Brismar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3677-9736","authenticated-orcid":false,"given":"Elizabeth V.","family":"Arkema","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"81","published-online":{"date-parts":[[2021,4,15]]},"reference":[{"key":"2024101711070315000_7.2.00028-2021.1","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1038\/s41572-019-0096-x","article-title":"Sarcoidosis","volume":"5","author":"Grunewald","year":"2019","journal-title":"Nat Rev Dis Primers"},{"key":"2024101711070315000_7.2.00028-2021.2","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.00477-2016"},{"key":"2024101711070315000_7.2.00028-2021.3","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.01815-2017"},{"key":"2024101711070315000_7.2.00028-2021.4","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.00767-2020"},{"key":"2024101711070315000_7.2.00028-2021.5","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2020.06.038"},{"key":"2024101711070315000_7.2.00028-2021.6","doi-asserted-by":"publisher","DOI":"10.1007\/s00408-017-0076-4"},{"key":"2024101711070315000_7.2.00028-2021.7","doi-asserted-by":"publisher","DOI":"10.1136\/pgmj.2008.067769"},{"key":"2024101711070315000_7.2.00028-2021.8","doi-asserted-by":"crossref","first-page":"15019","DOI":"10.1038\/nrdp.2015.19","article-title":"Type 2 diabetes mellitus","volume":"1","author":"DeFronzo","year":"2015","journal-title":"Nat Rev Dis Primers"},{"key":"2024101711070315000_7.2.00028-2021.9","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(18)32335-3"},{"key":"2024101711070315000_7.2.00028-2021.10","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1016\/j.mayocp.2017.09.015","article-title":"Increased risk of multimorbidity in patients with sarcoidosis: a population-based cohort study 1976 to 2013","volume":"92","author":"Ungprasert","year":"2017","journal-title":"Mayo Clin Proc"},{"key":"2024101711070315000_7.2.00028-2021.11","doi-asserted-by":"crossref","first-page":"13871","DOI":"10.1038\/srep13871","article-title":"Subsequent type 2 diabetes in patients with autoimmune disease","volume":"5","author":"Hemminki","year":"2015","journal-title":"Sci Rep"},{"key":"2024101711070315000_7.2.00028-2021.12","doi-asserted-by":"publisher","DOI":"10.1002\/dmrr.2486"},{"key":"2024101711070315000_7.2.00028-2021.13","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1177\/1060028017728297","article-title":"Optimizing the treatment of steroid-induced hyperglycemia","volume":"52","author":"Wallace","year":"2018","journal-title":"Ann Pharmacother"},{"key":"2024101711070315000_7.2.00028-2021.14","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.molmet.2019.12.012","article-title":"Glucocorticoid induces human beta cell dysfunction by involving riborepressor GAS5 LincRNA","volume":"32","author":"Esguerra","year":"2020","journal-title":"Mol Metab"},{"key":"2024101711070315000_7.2.00028-2021.15","doi-asserted-by":"publisher","DOI":"10.4158\/EP08331.RAR"},{"key":"2024101711070315000_7.2.00028-2021.16","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabres.2012.12.023"},{"key":"2024101711070315000_7.2.00028-2021.17","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.1994.00420010131015"},{"key":"2024101711070315000_7.2.00028-2021.18","unstructured":"Nationella Diabetesregistret. \u00c5rsrapport 2018. [Annual Report 2018.] 2018. www.ndr.nu\/pdfs\/Arsrapport_NDR_2018.pdf Date last accessed: 12 March 2021."},{"key":"2024101711070315000_7.2.00028-2021.19","unstructured":"Royston P , Lambert PC . Flexible Parametric Survival Analysis Using Stata: Beyond the Cox Model. College Station, Stata Press, 2011."},{"key":"2024101711070315000_7.2.00028-2021.20","doi-asserted-by":"publisher","DOI":"10.1002\/sim.1203"},{"key":"2024101711070315000_7.2.00028-2021.21","unstructured":"Lash TL , Fox MP , Fink AK . Applying Quantitative Bias Analysis to Epidemiologic Data. Dordrecht, Springer, 2011."},{"key":"2024101711070315000_7.2.00028-2021.22","unstructured":"R Core Team. R: A Language and Environment for Statistical Computing. Vienna, R Foundation for Statistical Computing, 2013."},{"key":"2024101711070315000_7.2.00028-2021.23","unstructured":"Therneau TM . A Package for Survival Analysis in R. 2020. https:\/\/cran.r-project.org\/web\/packages\/survival\/index.html Date last accessed: 12 March 2021."},{"key":"2024101711070315000_7.2.00028-2021.24","unstructured":"Clements M , Liu X-R , Lambert P , et al. rstpm2: Smooth Survival Models, Including Generalized Survival Models. 2019. https:\/\/cran.r-project.org\/web\/packages\/rstpm2\/index.html Date last accessed: 12 March 2021 ."},{"key":"2024101711070315000_7.2.00028-2021.25","doi-asserted-by":"crossref","first-page":"2216","DOI":"10.1016\/j.clinthera.2017.09.011","article-title":"Long-term systemic corticosteroid exposure: a systematic literature review","volume":"39","author":"Rice","year":"2017","journal-title":"Clin Ther"},{"key":"2024101711070315000_7.2.00028-2021.26","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1080\/17476348.2020.1707672","article-title":"Knowing when to use steroids, immunosuppressants or biologics for the treatment of sarcoidosis","volume":"14","author":"Pande","year":"2020","journal-title":"Expert Rev Respir Med"},{"key":"2024101711070315000_7.2.00028-2021.27","doi-asserted-by":"publisher","DOI":"10.1016\/j.rmed.2017.09.003"},{"key":"2024101711070315000_7.2.00028-2021.28","unstructured":"Svensk Lungmedicinsk F\u00f6rening. V\u00e5rdprogram f\u00f6r Sarkoidos. [Care Program for Sarcoidosis.] 2019. http:\/\/slmf.se\/wp-content\/uploads\/2018\/08\/VP_sarkoidos_web_180117_0.pdf Date last accessed: 12 March 2021."},{"key":"2024101711070315000_7.2.00028-2021.29","doi-asserted-by":"publisher","DOI":"10.1378\/chest.14-1099"},{"key":"2024101711070315000_7.2.00028-2021.30","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.01397-2017"},{"key":"2024101711070315000_7.2.00028-2021.31","doi-asserted-by":"publisher","DOI":"10.1016\/j.rmed.2016.10.003"},{"key":"2024101711070315000_7.2.00028-2021.32","doi-asserted-by":"publisher","DOI":"10.1038\/nri2925"},{"key":"2024101711070315000_7.2.00028-2021.33","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabres.2010.04.012"},{"key":"2024101711070315000_7.2.00028-2021.34","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1016\/S2213-8587(15)00316-2","article-title":"Relation of active, passive, and quitting smoking with incident type 2 diabetes: a systematic review and meta-analysis","volume":"3","author":"Pan","year":"2015","journal-title":"Lancet Diabetes Endocrinol"},{"key":"2024101711070315000_7.2.00028-2021.35","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.200909-1338OC"},{"key":"2024101711070315000_7.2.00028-2021.36","doi-asserted-by":"crossref","first-page":"105846","DOI":"10.1016\/j.rmed.2019.105846","article-title":"Sarcoidosis diagnosis and treatment in Sweden: a register-based assessment of variations by region and calendar period","volume":"161","author":"Rossides","year":"2020","journal-title":"Respir Med"}],"container-title":["ERJ Open Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1183\/23120541.00028-2021","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,24]],"date-time":"2025-02-24T05:07:42Z","timestamp":1740373662000},"score":1,"resource":{"primary":{"URL":"https:\/\/publications.ersnet.org\/lookup\/doi\/10.1183\/23120541.00028-2021"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4]]},"references-count":36,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2021,5,24]]},"published-print":{"date-parts":[[2021,4]]}},"alternative-id":["10.1183\/23120541.00028-2021"],"URL":"https:\/\/doi.org\/10.1183\/23120541.00028-2021","relation":{},"ISSN":["2312-0541"],"issn-type":[{"value":"2312-0541","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,4]]}}}